Sanofi-Aventis, International Vaccine Institute Partner
Sanofi Pasteur, the vaccines division of pharma company Sanofi-Aventis Group, is partnering with the International Vaccine Institute to support the recently launched Dengue Vaccine Initiative.
The two groups aim to raise awareness and move dengue vaccination higher on the global health agenda. Currently, there is no specific treatment available for dengue fever, a virus-based disease spread by mosquitoes. The infectious disease is a threat to nearly half of the world's population and a public health priority in many countries of Latin America and Asia where epidemics occur.
"The fight against dengue requires a strong global commitment from all public health partners," says Olivier Charmeil, senior vice president, vaccines at Paris-based Sanofi-Aventis, in a statement. The company's U.S. headquarters is in Bridgewater, N.J.
There is no cure for the disease, but Sanofi has the world's most clinically advanced vaccine candidate, which entered final clinical testing in Australia in November.
The next step is facilitating discussions among policymakers, with the objective of ensuring that once licensed, the vaccine will be made available to those populations that need it most in a timely manner, Charmeil adds.
The French drugmaker has said in the past that a vaccine against dengue fever could potentially generate sales of more than $1 billion a year, according to Reuters.
The International Vaccine Institute, a Seoul-based organization set up by the United Nations Development Program, announced the launch of the Dengue Vaccine Initiative earlier this month. The effort is collaboration with the Sabin Vaccine Institute, the Johns Hopkins University, and the World Health Organization, to support development of vaccines to control dengue fever.
Of the estimated 220 million people infected annually, two million -- mostly children -- develop dengue hemorrhagic fever (DHF), a severe form of the disease. DHF is a leading cause of hospitalization, placing tremendous pressure on strained medical resources and having a heavy economic and societal impact.
Recent Marketing Daily Articles
-
Mondelez Goes Social, AR In Band-Tour Sponsorship May 23, 8:14 a.m.
In two firsts for the company, Mondelez International is using a fan as a social media ... -
Beer Category Grows Most In Brand Rankings May 23, 12:40 a.m.
Beer was the highest growth category in this year’s BrandZ rankings -- up 36% year-over-year, according ... -
Saks Soars; Target Misses May 22, 6:10 p.m.
It’s a buzzy week for retailers. While mass chains such as Target and Lowe’s say the ... -
Cricket Makes More From Less May 22, 4 p.m.
Prepaid wireless carrier Cricket Communications is taking direct aim at customers of the larger, post-paid companies ... -
Seattle's Best Promos New Drive-Thru Format May 22, 3:43 p.m.
Seattle’s Best Coffee has simultaneously opened 10 “drive-thrus” in the Dallas/Fort Worth area. This marks the ... -
Balance Bar Unveils 1st National TV Ads In 10+ Years May 22, 6:26 a.m.
Balance Bar -- one of America’s first nutrition/energy bar products (launched in 1992) -- is looking ... -
Crowne Plaza Measures PGA Tour Sleep Habits May 21, 11:21 p.m.
Just in time for the Crowne Plaza Invitational at Colonial tournament this week, Crowne Plaza Hotels ... -
Dodge Goes Social With 'Defiance' May 21, 4:44 p.m.
Chrysler LLC's Dodge, which has category-exclusive sponsorship of the "Defiance" TV show and online game for ... -
Microsoft Unveils Xbox One May 21, 2:34 p.m.
For a presentation that was obstensibly about a new gaming console, Microsoft’s unveiling of its next-generation ... -
Telematics Ecosystem Booming, But Caution Advised May 21, 2:05 p.m.
The head of marketing for, say, Starbucks, is probably thinking about cars. Specifically, how to go ...
Be the first to comment on "Sanofi-Aventis, International Vaccine Institute Partner "
Leave a Comment